Current and Emerging Trials, Mechanisms, and Agents in B-Cell Directed Therapies: Webcasts

Webcasts

Technical Requirements
(will appear in new window)

Released 2009: Advances in B-Cell Biology in the Treatment of Autoimmune and Inflammatory Diseases (Highlights of the Fall 2008 National Rheumatology Meeting)

Part 1: Advances in B-Cell Biology in the Treatment of Autoimmune and Inflammatory Diseases Gregg J. Silverman, MD University of California	Part 2: B-Cell–Directed Therapy for Rheumatoid Arthritis Marc D. Cohen, MD National Jewish Medical and Research Center
Part 3: Assessing Immunocompetence in Patients Treated With B-Cell–Directed Therapies Leonard H. Calabrese, DO Cleveland Clinic	Part 4: The Use of B-Cell–Directed Therapies in SLE, Vasculitis, and Other Autoimmune Diseases Jonathan Kay, MD Massachusetts General Hospital

Released 2009: B-Cell Biology and B-Cell–Targeted Therapies for Autoimmune Rheumatic Diseases: The Role of the Allied Health Professional (Highlights of the Fall 2008 National Rheumatology Meeting)

Part 1: Biologic Therapies and B-Cell–Targeting
for Rheumatoid Arthritis and Allied Conditions:
The Role of the Allied Health Professional
Leonard H. Calabrese, DO
Cleveland Clinic

Part 2: The Role of the Allied Health Professional in Biologic Therapy for Rheumatoid Arthritis: Focus on Vaccines
Elizabeth Kirchner, MS, CNP
Cleveland Clinic